1. Home
  2. XNCR vs FLNC Comparison

XNCR vs FLNC Comparison

Compare XNCR & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • FLNC
  • Stock Information
  • Founded
  • XNCR 1997
  • FLNC 2018
  • Country
  • XNCR United States
  • FLNC United States
  • Employees
  • XNCR 250
  • FLNC N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • FLNC Industrial Machinery/Components
  • Sector
  • XNCR Health Care
  • FLNC Miscellaneous
  • Exchange
  • XNCR Nasdaq
  • FLNC Nasdaq
  • Market Cap
  • XNCR 625.6M
  • FLNC 533.2M
  • IPO Year
  • XNCR 2013
  • FLNC 2021
  • Fundamental
  • Price
  • XNCR $8.20
  • FLNC $5.37
  • Analyst Decision
  • XNCR Buy
  • FLNC Buy
  • Analyst Count
  • XNCR 9
  • FLNC 18
  • Target Price
  • XNCR $30.13
  • FLNC $9.31
  • AVG Volume (30 Days)
  • XNCR 970.6K
  • FLNC 5.7M
  • Earning Date
  • XNCR 05-07-2025
  • FLNC 05-07-2025
  • Dividend Yield
  • XNCR N/A
  • FLNC N/A
  • EPS Growth
  • XNCR N/A
  • FLNC N/A
  • EPS
  • XNCR N/A
  • FLNC N/A
  • Revenue
  • XNCR $127,228,000.00
  • FLNC $2,329,871,000.00
  • Revenue This Year
  • XNCR N/A
  • FLNC $18.14
  • Revenue Next Year
  • XNCR $25.05
  • FLNC $21.77
  • P/E Ratio
  • XNCR N/A
  • FLNC N/A
  • Revenue Growth
  • XNCR N/A
  • FLNC 6.08
  • 52 Week Low
  • XNCR $7.16
  • FLNC $3.46
  • 52 Week High
  • XNCR $27.24
  • FLNC $26.12
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 37.73
  • FLNC 60.56
  • Support Level
  • XNCR $7.89
  • FLNC $3.93
  • Resistance Level
  • XNCR $9.37
  • FLNC $6.53
  • Average True Range (ATR)
  • XNCR 0.83
  • FLNC 0.43
  • MACD
  • XNCR -0.13
  • FLNC 0.22
  • Stochastic Oscillator
  • XNCR 9.09
  • FLNC 57.30

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About FLNC Fluence Energy Inc.

Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: